Status:
UNKNOWN
Methadone Anesthesia For Kidney Transplant Receptors
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
Renal Failure Chronic
Surgery
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Intraoperative methadone or fentanyl will be administered to patients submitted to kidney transplant surgery. Postoperative pain, analgesic consumption and side effects will be evaluated
Detailed Description
Despite recent developments in postoperative pain control, many patients still experience moderate or severe pain after surgery. It is estimated that severe postoperative pain occurs in 20 to 40% of s...
Eligibility Criteria
Inclusion
- Patients over 18 years of age
- With indication for kidney transplant surgery
- Who sign the informed consent form
Exclusion
- Patients who refuse to participate in the study
- Known allergy to any drug used in this protocol
- Presence of stage III or IV congestive heart failure
- Increase in QT interval on electrocardiogram (QT\> 500 msec)
- Preemptive kidney transplantation (defined by transplantation in a patient who has not yet started kidney replacement therapy).
Key Trial Info
Start Date :
May 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT04908345
Start Date
May 17 2021
End Date
January 1 2022
Last Update
June 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital das Clínicas da FMUSP
São Paulo, São Paulo, Brazil, 05403-000